Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Depression 2Unipolar Major Depression 1Radiation Injuries 1Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Depressive Disorder, Major 1

Interventions

Radiotherapy 38Radiotherapy, Intensity-Modulated 12Cisplatin 12Amifostine 11Paclitaxel 7Carboplatin 7Radiosurgery 6Etoposide 5Brachytherapy 5Surgical Procedures, Operative 4Low-Level Light Therapy 4Donepezil 4Chemotherapy, Adjuvant 4Bevacizumab 4sargramostim 3Surveys and Questionnaires 3Radiation 3Proton Therapy 3Neuropsychological Tests 3Mental Status and Dementia Tests 3Magnetic Resonance Spectroscopy 3Heavy Ion Radiotherapy 3Filgrastim 3Diet Therapy 3Chemoradiotherapy 3Blood Specimen Collection 3Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Patient Reported Outcome Measures 2Lithium 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Injuries × Vortioxetine × Clear all
NCT04818099 2021-03-26

Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3 Unknown
208 enrolled
Head & Neck

Depression, Head and Neck Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡